Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Friendly Fire

<< Previous

Bullboard Posts

Next >>

Comment by Gtyabackon Jun 12, 2021 6:49am

168 Views

Post# 33377351

RE:RE:RE:RE:RE:RE:Friendly Fire

I saw that he bought a cpl million shares the same day. Or so a site reporting insider buys shows he did. Maybe he overextended himself. I don't no. I'm kinda new to this whole thing. But that made me happy when I saw he bought all those shares the same day. There's been lots of insider buying which is good or is that his salary .

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec